Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 22, 2023, titled "Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study".
Press Release Mar 22 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Mar 19 2023
- Press Release Feb 10 2023
- Press Release Jan 31 2023
- Press Release Jan 30 2023
- Press Release Jan 25 2023
Later from Sun Pharmaceutical Industries
- Press Release Apr 25 2023
- Press Release May 26 2023
- Press Release May 30 2023
- Sun Pharma Announces China NMPA Approval for ILUMETRI for Treatment of Adults with Moderate-To-Severe Plaque Psoriasis
- Press Release Jun 19 2023
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries